{"id":389078,"date":"2020-11-27T10:12:45","date_gmt":"2020-11-27T15:12:45","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=389078"},"modified":"2020-11-27T10:12:45","modified_gmt":"2020-11-27T15:12:45","slug":"calliditas-therapeutics-nomination-committee-for-the-agm-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/","title":{"rendered":"Calliditas Therapeutics’ nomination committee for the AGM 2021"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n STOCKHOLM<\/span>, Nov. 27, 2020<\/span> \/PRNewswire\/ — Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2021.<\/b>\u00a0<\/b><\/p>\n

The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting on September 14, 2017<\/span>, consists of:<\/p>\n

\u00b7 Patrick Sobocki, appointed by Stiftelsen Industrifonden<\/p>\n

\u00b7 Spike Loy<\/span>, appointed by BVF<\/p>\n

\u00b7 Karl Tobieson, appointed by Linc AB<\/p>\n

\u00b7 Elmar Schnee<\/span> (chairman of the board of directors) <\/p>\n

The nomination committee shall, before the annual general meeting 2021, prepare a proposal for the election of chairman and other members of the board of directors, the election of chairman of the annual meeting, election of auditors, the determination of fees and matters pertaining thereto.<\/p>\n

For more information please visit:<\/p>\n

\n https:\/\/www.calliditas.se\/en\/nomination-committee-2314\/<\/a>\n <\/p>\n

Shareholders who wish to submit proposals to the nomination committee for the annual general meeting on May 27, 2021<\/span> can do so by e-mail to finance@calliditas.com<\/a>. Proposals should be submitted to the nomination committee before April 5, 2021<\/span>.<\/p>\n

\n For further information, please contact<\/b>: <\/p>\n

\n Fredrik Johansson<\/span>, CFO at Calliditas<\/p>\n

Email: fredrik.johansson@calliditas.com<\/a><\/p>\n

Telephone: +46\u00a0703 52 91 90<\/p>\n

\n The information was submitted for publication, through the agency of the contact person set out above, at 4.00 p.m on November 27, 2020<\/span>.<\/i>\n <\/p>\n

\n About Calliditas Therapeutics<\/b>\n <\/p>\n

Calliditas Therapeutics is a specialty pharmaceutical company based in Stockholm, Sweden<\/span> focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. Calliditas’ lead product candidate, Nefecon, is a proprietary, novel oral formulation of budesonide, an established, highly potent local immunosuppressant, for the treatment of the autoimmune renal disease IgA nephropathy, or IgAN, for which there is a high unmet medical need and there are no approved treatments. Calliditas is running a global Phase 3 study within IgAN and, if approved, aims to commercialize Nefecon in the United States<\/span>. Calliditas is listed on Nasdaq Stockholm (ticker: CALTX) and the Nasdaq Global Select Market (ticker: CALT). Visit www.calliditas.com<\/a> for further information.<\/p>\n

This information was brought to you by Cision http:\/\/news.cision.com<\/a><\/p>\n

\n https:\/\/news.cision.com\/calliditas-therapeutics\/r\/calliditas-therapeutics–nomination-committee-for-the-agm-2021,c3245088<\/a>\n <\/p>\n

The following files are available for download:<\/p>\n

\n\n\n
\n

\n
\n https:\/\/mb.cision.com\/Main\/16574\/3245088\/1340988.pdf<\/a>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Release<\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n \"Cision\" View original content:http:\/\/www.prnewswire.com\/news-releases\/calliditas-therapeutics-nomination-committee-for-the-agm-2021-301181201.html<\/a><\/p>\n

SOURCE Calliditas Therapeutics<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire STOCKHOLM, Nov. 27, 2020 \/PRNewswire\/ — Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2021.\u00a0 The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting on September 14, 2017, consists of: \u00b7 Patrick Sobocki, appointed by Stiftelsen Industrifonden \u00b7 Spike Loy, appointed by BVF \u00b7 Karl Tobieson, appointed by Linc AB \u00b7 Elmar Schnee (chairman of the board of directors) The nomination committee shall, before the annual general meeting 2021, prepare a proposal for the election of chairman and other members of the board of directors, the election of chairman of the annual meeting, election of auditors, the determination of fees and matters pertaining thereto. For … <\/p>\n

Continue reading “Calliditas Therapeutics’ nomination committee for the AGM 2021”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-389078","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCalliditas Therapeutics' nomination committee for the AGM 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Calliditas Therapeutics' nomination committee for the AGM 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire STOCKHOLM, Nov. 27, 2020 \/PRNewswire\/ — Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2021.\u00a0 The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting on September 14, 2017, consists of: \u00b7 Patrick Sobocki, appointed by Stiftelsen Industrifonden \u00b7 Spike Loy, appointed by BVF \u00b7 Karl Tobieson, appointed by Linc AB \u00b7 Elmar Schnee (chairman of the board of directors) The nomination committee shall, before the annual general meeting 2021, prepare a proposal for the election of chairman and other members of the board of directors, the election of chairman of the annual meeting, election of auditors, the determination of fees and matters pertaining thereto. For … Continue reading "Calliditas Therapeutics’ nomination committee for the AGM 2021"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-27T15:12:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO05212&sd=2020-11-27\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Calliditas Therapeutics’ nomination committee for the AGM 2021\",\"datePublished\":\"2020-11-27T15:12:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/\"},\"wordCount\":376,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO05212&sd=2020-11-27\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/\",\"name\":\"Calliditas Therapeutics' nomination committee for the AGM 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO05212&sd=2020-11-27\",\"datePublished\":\"2020-11-27T15:12:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO05212&sd=2020-11-27\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO05212&sd=2020-11-27\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Calliditas Therapeutics’ nomination committee for the AGM 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Calliditas Therapeutics' nomination committee for the AGM 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/","og_locale":"en_US","og_type":"article","og_title":"Calliditas Therapeutics' nomination committee for the AGM 2021 - Market Newsdesk","og_description":"PR Newswire STOCKHOLM, Nov. 27, 2020 \/PRNewswire\/ — Calliditas Therapeutics AB (publ.) publishes the nomination committee’s composition for the AGM in 2021.\u00a0 The nomination committee, which is appointed in accordance with the principles adopted by the extraordinary general meeting on September 14, 2017, consists of: \u00b7 Patrick Sobocki, appointed by Stiftelsen Industrifonden \u00b7 Spike Loy, appointed by BVF \u00b7 Karl Tobieson, appointed by Linc AB \u00b7 Elmar Schnee (chairman of the board of directors) The nomination committee shall, before the annual general meeting 2021, prepare a proposal for the election of chairman and other members of the board of directors, the election of chairman of the annual meeting, election of auditors, the determination of fees and matters pertaining thereto. For … Continue reading \"Calliditas Therapeutics’ nomination committee for the AGM 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-27T15:12:45+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO05212&sd=2020-11-27","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Calliditas Therapeutics’ nomination committee for the AGM 2021","datePublished":"2020-11-27T15:12:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/"},"wordCount":376,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO05212&sd=2020-11-27","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/","name":"Calliditas Therapeutics' nomination committee for the AGM 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO05212&sd=2020-11-27","datePublished":"2020-11-27T15:12:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO05212&sd=2020-11-27","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO05212&sd=2020-11-27"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/calliditas-therapeutics-nomination-committee-for-the-agm-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Calliditas Therapeutics’ nomination committee for the AGM 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389078","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=389078"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389078\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=389078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=389078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=389078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}